https://edgen.pre.edgen.tech/news/post/nvidia-rival-cerebras-lifts-ipo-price-to-target-38-billion2026-05-09T00:22:56.962Zdaily1Edgen Stocken2026-05-09T00:22:56.962+00:00Nvidia Rival Cerebras Lifts IPO Price to Target $3.8 Billionhttps://static.edgen.tech/news/images/nvidia-rival-cerebras-lifts-ipo-price-to-target-38-billion-20260509.pngNvidia Rival Cerebras Lifts IPO Price to Target $3.8 Billion https://edgen.pre.edgen.tech/news/post/real-brokerage-revenue-jumps-32-on-agent-growth-ahead-of-remax-deal2026-05-08T23:40:55.246Zdaily1Edgen Stocken2026-05-08T23:40:55.246+00:00Real Brokerage Revenue Jumps 32% on Agent Growth Ahead of RE/MAX Dealhttps://static.edgen.tech/news/images/real-brokerage-revenue-jumps-32-on-agent-growth-ahead-of-remax-deal-20260508.pngReal Brokerage Revenue Jumps 32% on Agent Growth Ahead of RE/MAX Deal https://edgen.pre.edgen.tech/news/post/engene-stock-plunges-76-on-bladder-cancer-drug-durability-questions2026-05-08T23:40:49.466Zdaily1Edgen Stocken2026-05-08T23:40:49.466+00:00enGene Stock Plunges 76% on Bladder Cancer Drug Durability Questionshttps://static.edgen.tech/news/images/engene-stock-plunges-76-on-bladder-cancer-drug-durability-questions-20260508.pngenGene Stock Plunges 76% on Bladder Cancer Drug Durability Questions https://edgen.pre.edgen.tech/news/post/russia-ukraine-agree-to-3-day-ceasefire-and-1000-prisoner-swap2026-05-08T23:22:19.807Zdaily1Edgen Stocken2026-05-08T23:22:19.807+00:00Russia, Ukraine Agree to 3-Day Ceasefire and 1,000-Prisoner Swaphttps://static.edgen.tech/news/images/russia-ukraine-agree-to-3-day-ceasefire-and-1000-prisoner-swap-20260508.pngRussia, Ukraine Agree to 3-Day Ceasefire and 1,000-Prisoner Swap https://edgen.pre.edgen.tech/news/post/tessera-labs-secures-60-million-to-modernize-legacy-erp-with-ai2026-05-08T22:56:39.649Zdaily1Edgen Stocken2026-05-08T22:56:39.649+00:00Tessera Labs Secures $60 Million to Modernize Legacy ERP With AIhttps://static.edgen.tech/news/images/tessera-labs-secures-60-million-to-modernize-legacy-erp-with-ai-20260508.pngTessera Labs Secures $60 Million to Modernize Legacy ERP With AI https://edgen.pre.edgen.tech/news/post/hong-kong-sfc-warns-2-firms-for-unlicensed-crypto-ipo-services2026-05-08T22:48:58.659Zdaily1Edgen Stocken2026-05-08T22:48:58.659+00:00Hong Kong SFC warns 2 firms for unlicensed crypto IPO serviceshttps://static.edgen.tech/news/images/hong-kong-sfc-warns-2-firms-for-unlicensed-crypto-ipo-services-20260508.pngHong Kong SFC warns 2 firms for unlicensed crypto IPO services https://edgen.pre.edgen.tech/news/post/quinstreet-q3-revenue-jumps-28-to-346-million-on-ai-boost2026-05-08T22:46:53.888Zdaily1Edgen Stocken2026-05-08T22:46:53.888+00:00QuinStreet Q3 revenue jumps 28% to $346 million on AI boosthttps://static.edgen.tech/news/images/quinstreet-q3-revenue-jumps-28-to-346-million-on-ai-boost-20260508.pngQuinStreet Q3 revenue jumps 28% to $346 million on AI boost https://edgen.pre.edgen.tech/news/post/humacyte-faces-investigation-from-ksf-over-fda-application-delay2026-05-08T22:46:50.047Zdaily1Edgen Stocken2026-05-08T22:46:50.047+00:00Humacyte Faces Investigation From KSF Over FDA Application Delayhttps://static.edgen.tech/news/images/humacyte-faces-investigation-from-ksf-over-fda-application-delay-20260508.pngHumacyte Faces Investigation From KSF Over FDA Application Delay https://edgen.pre.edgen.tech/news/post/hyperliquid-strategies-swings-to-1525-million-profit-on-hype-token-rally2026-05-08T22:46:12.071Zdaily1Edgen Stocken2026-05-08T22:46:12.071+00:00Hyperliquid Strategies swings to $152.5 million profit on HYPE token rallyhttps://static.edgen.tech/news/images/hyperliquid-strategies-swings-to-1525-million-profit-on-hype-token-rally-20260508.pngHyperliquid Strategies swings to $152.5 million profit on HYPE token rally https://edgen.pre.edgen.tech/news/post/palvella-to-file-for-qtorin-approval-after-230m-financing2026-05-08T22:46:01.031Zdaily1Edgen Stocken2026-05-08T22:46:01.031+00:00Palvella to file for QTORIN approval after $230M financinghttps://static.edgen.tech/news/images/palvella-to-file-for-qtorin-approval-after-230m-financing-20260508.pngPalvella to file for QTORIN approval after $230M financing https://edgen.pre.edgen.tech/news/post/trubridge-surpasses-q1-eps-estimates-by-162026-05-08T22:44:05.283Zdaily1Edgen Stocken2026-05-08T22:44:05.283+00:00TruBridge Surpasses Q1 EPS Estimates by 16%https://static.edgen.tech/news/images/trubridge-surpasses-q1-eps-estimates-by-16-20260508.pngTruBridge Surpasses Q1 EPS Estimates by 16% https://edgen.pre.edgen.tech/news/post/american-aires-trading-halted-after-failure-to-file-1-annual-report2026-05-08T22:43:45.089Zdaily1Edgen Stocken2026-05-08T22:43:45.089+00:00American Aires Trading Halted After Failure to File 1 Annual Reporthttps://static.edgen.tech/news/images/american-aires-trading-halted-after-failure-to-file-1-annual-report-20260508.pngAmerican Aires Trading Halted After Failure to File 1 Annual Report https://edgen.pre.edgen.tech/news/post/pbf-chalmette-refinery-offline-after-explosion-halts-190000-bpd2026-05-08T22:41:46.875Zdaily1Edgen Stocken2026-05-08T22:41:46.875+00:00PBF Chalmette Refinery Offline After Explosion Halts 190,000 BPDhttps://static.edgen.tech/news/images/pbf-chalmette-refinery-offline-after-explosion-halts-190000-bpd-20260508.pngPBF Chalmette Refinery Offline After Explosion Halts 190,000 BPD https://edgen.pre.edgen.tech/news/post/disneys-abc-challenges-fcc-over-1st-amendment-rights2026-05-08T22:14:43.084Zdaily1Edgen Stocken2026-05-08T22:14:43.084+00:00Disney's ABC challenges FCC over 1st amendment rightshttps://static.edgen.tech/news/images/disneys-abc-challenges-fcc-over-1st-amendment-rights-20260508.pngDisney's ABC challenges FCC over 1st amendment rights https://edgen.pre.edgen.tech/news/post/polestar-loss-widens-to-383-million-despite-7-volume-growth2026-05-08T22:00:30.636Zdaily1Edgen Stocken2026-05-08T22:00:30.636+00:00Polestar loss widens to $383 million despite 7% volume growthhttps://static.edgen.tech/news/images/polestar-loss-widens-to-383-million-despite-7-volume-growth-20260508.pngPolestar loss widens to $383 million despite 7% volume growth https://edgen.pre.edgen.tech/news/post/profound-medical-revenue-more-than-doubles-beats-q1-estimates2026-05-08T21:59:25.145Zdaily1Edgen Stocken2026-05-08T21:59:25.145+00:00Profound Medical revenue more than doubles, beats Q1 estimateshttps://static.edgen.tech/news/images/profound-medical-revenue-more-than-doubles-beats-q1-estimates-20260508.pngProfound Medical revenue more than doubles, beats Q1 estimates https://edgen.pre.edgen.tech/news/post/digi-power-x-boosts-equity-offering-to-175-million-for-ai-build-out2026-05-08T21:58:50.505Zdaily1Edgen Stocken2026-05-08T21:58:50.505+00:00Digi Power X boosts equity offering to $175 million for AI build-outhttps://static.edgen.tech/news/images/digi-power-x-boosts-equity-offering-to-175-million-for-ai-build-out-20260508.pngDigi Power X boosts equity offering to $175 million for AI build-out https://edgen.pre.edgen.tech/news/post/argenx-wins-broad-fda-approval-for-vyvgart-in-all-adult-gmg-patients2026-05-08T21:57:12.408Zdaily1Edgen Stocken2026-05-08T21:57:12.408+00:00Argenx Wins Broad FDA Approval for Vyvgart in All Adult gMG Patientshttps://static.edgen.tech/news/images/argenx-wins-broad-fda-approval-for-vyvgart-in-all-adult-gmg-patients-20260508.pngArgenx Wins Broad FDA Approval for Vyvgart in All Adult gMG Patients https://edgen.pre.edgen.tech/news/post/analytixinsight-halted-as-regulator-issues-cease-trade-order2026-05-08T21:52:47.564Zdaily1Edgen Stocken2026-05-08T21:52:47.564+00:00AnalytixInsight Halted as Regulator Issues Cease Trade Orderhttps://static.edgen.tech/news/images/analytixinsight-halted-as-regulator-issues-cease-trade-order-20260508.pngAnalytixInsight Halted as Regulator Issues Cease Trade Order https://edgen.pre.edgen.tech/news/post/us-adds-115000-jobs-in-april-shifting-fed-focus-to-inflation2026-05-08T21:50:43.853Zdaily1Edgen Stocken2026-05-08T21:50:43.853+00:00US adds 115,000 jobs in April, shifting Fed focus to inflationhttps://static.edgen.tech/news/images/us-adds-115000-jobs-in-april-shifting-fed-focus-to-inflation-20260508.pngUS adds 115,000 jobs in April, shifting Fed focus to inflation